Everything below concerns counterion. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2026-03-08. Numbers and descriptions here follow the published literature rather than marketing material.
Handling practice centers on limiting moisture, heat, and mechanical stress. Powder is typically allowed to reach room temperature before opening so that condensation does not form on the contents, and solutions are prepared with sterile or low-particulate water. Peptides can adsorb to certain plastics and membrane filters, so container and filter material is sometimes specified to reduce losses at low concentrations. Working aliquots are usually frozen separately rather than sampled repeatedly from one stock. Recording lot number, preparation date, and storage conditions supports later comparison between experiments.
Identity and purity are usually assessed by reversed-phase high-performance liquid chromatography, which separates the target peptide from truncated sequences and other synthesis by-products. Mass spectrometry, typically electrospray ionization coupled to liquid chromatography, confirms the expected mass and helps detect modifications. Amino acid analysis can verify composition when residue-level confirmation is needed. Because common impurities differ from the target by only one or two residues, chromatographic resolution often matters more than a single headline purity percentage. Impurity profiles are most informative when compared against a validated reference standard.
Published storage guidance follows general peptide practice rather than product-specific studies. The dry powder is typically kept at minus 20 degrees Celsius, away from light and moisture. Once reconstituted, solutions are generally refrigerated and used over days to weeks, because the aqueous environment slowly promotes hydrolysis and oxidation. Long-term data on degradation rates or breakdown products are sparse. Stated shelf lives from different producers vary widely, reflecting the absence of a shared reference standard.
BPC-157 is a synthetic peptide built from fifteen amino acid residues. Its sequence comes from a larger protein fragment that researchers isolated from human gastric juice and described as a body protection compound. The fragment contains glycine, glutamic acid, five prolines, lysine, alanine, two aspartic acids, leucine, and valine. The number 157 in the name refers to the position of the stretch within the parent protein. Material used in laboratories is manufactured rather than extracted from stomach fluid.
The molecule carries 15 residues, a molar mass near 1419.5 g/mol, and the formula C62H98N16O22. Its structure features a proline-rich central region, a pair of adjacent aspartic acid residues, and no cysteine. The absence of cysteine means no disulfide bonds can form, which simplifies refolding and reconstitution. Suppliers usually ship the material as a freeze-dried powder that appears white to off-white. It dissolves readily in water and in saline solutions.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Typical lyophilized form |
| Solubility | Freely soluble in water | Also dissolves in common polar solvents |
| Storage temperature | Minus 20 degrees Celsius or lower | Applies to dry powder, desiccated and dark |
| Typical analytical methods | Reversed-phase HPLC and mass spectrometry | Used together for purity and identity |
| Primary degradation route | Hydrolysis and aggregation | No cysteine present, so disulfide formation is unlikely |
Doses in the literature are usually expressed in micrograms or nanograms per kilogram of body weight. Investigators have administered the peptide by several routes, including injection and oral delivery, depending on the question asked. Route and dose vary widely across studies, which complicates direct comparison of results. Many papers report effects at low doses, but the absence of a standardized protocol limits generalization. Reporting practice differs between research groups.
Some properties, such as the peptide's sequence and molecular mass, are firmly established. Other claims, particularly about mechanism and clinical benefit, remain open questions. Proposed mechanisms include effects on nitric oxide signaling and on cell migration, but these are hypotheses supported by limited evidence. Reviewers often note that the field lacks large controlled human trials. Positive animal findings are best treated as signals for further study rather than as settled conclusions.
Most published studies examine BPC-157 in animal models rather than in humans. Common subjects include rats and mice, and researchers often use models of tissue injury, surgery, or induced inflammation. Reported endpoints include healing rates, blood vessel formation, and markers of tissue repair. These designs provide controlled comparisons, but findings in animals do not automatically transfer to people. Human clinical data remain limited and are frequently described as preliminary.
Several mechanisms have been proposed to explain the activity observed in animal models. The most frequently cited involve signaling through vascular endothelial growth factor receptor 2 and modulation of the nitric oxide system. Researchers have also described interactions with protective pathways in the gut lining. These proposed mechanisms appear in the literature as hypotheses supported by preclinical observations, not as confirmed pathways in humans. The precise way the peptide produces its reported effects, and whether those effects carry across species, remain areas of active and unresolved investigation.
BPC-157 is a synthetic pentadecapeptide, meaning it consists of fifteen amino acids joined in a single chain. Its sequence is Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, a fragment corresponding to part of a larger protein found in human gastric juice. The peptide was first described in the 1990s by researchers in Zagreb who were studying gastric protective factors. It is not a naturally circulating hormone; it is a laboratory-made fragment derived from a stomach protein. The name is an abbreviation of body protection compound, with the number referring to the fragment's position in the source protein.
The main chemical liabilities of this sequence are peptide-bond hydrolysis and possible aspartate-related reactions, since the peptide contains aspartic acid residues but no cysteine, methionine, or tryptophan. Absence of those three residues removes the most common oxidation and disulfide pathways from consideration. Studies of related peptides indicate that aspartate isomerisation and aspartimide formation occur most readily at Asp-Gly and Asp-Ala positions, and open questions remain about how quickly those reactions proceed under ordinary laboratory conditions. Storage guidance typically emphasises cool, dry, dark conditions to slow hydrolysis.
Identity and purity are usually assessed with reversed-phase high-performance liquid chromatography, often paired with mass spectrometry using electrospray or MALDI ionisation. Amino acid analysis and peptide mapping by enzymatic digestion provide additional sequence-level confirmation. Purity is commonly reported as an area percentage from a chromatographic trace, and water content can be measured by Karl Fischer titration. Reported masses may differ by tens of daltons between sources because preparations can contain acetate or trifluoroacetate counterions, and such differences are not by themselves evidence of a different peptide.
Adrien-Marie Legendre at PlanetMath. The True Face of Adrien-Marie Legendre (Portrait of Legendre) Biography at Fermat's Last Theorem Blog References for Adrien-Marie Legendre (in French) Eléments de géométrie (Paris : F. Didot, 1817) Elements of geometry and trigonometry, from the works of A. M. Legendre. Revised and adapted to the course of mathematical instruction in the United States, by Charles Davies. (New York: A. S. Barnes & co., 1858) : English translation of the above text Mémoires sur la méthode des moindres quarrés, et sur l'attraction des ellipsoïdes homogènes (1830) Théorie des nombres (Paris : Firmin-Didot, 1830) Traité des fonctions elliptiques et des intégrales eulériennes (Paris : Huzard-Courcier, 1825–1828) Nouvelles Méthodes pour la Détermination des Orbites des Comètes (Paris : Courcier, 1806) Essai sur la Théorie des Nombres (Paris : Duprat, 1798) Exercices de Calcul Intégral V.3 (Paris : Courcier, 1816) Correspondance mathématique avec Legendre in C. G. J. Jacobis gesammelte Werke (Berlin: 1852)
== Function == FGFR1OP2, when fused with the fibroblast growth factor receptor 1 (FGFR1), is shown to cause myeloproliferative syndrome. The protein encoded by the FGFR1 gene belongs to the fibroblast growth factor receptor family. FGFRs usually contain an extracellular ligand binding domain, a single transmembrane domain, and an intracellular tyrosine kinase domain. The extracellular domain specifies which ligand the receptor will bind to and mediates ligand-induced receptor dimerization. When FGFR1OP2 is fused to FGFR1, it may exhibit constitutive kinase activity. Furthermore, FGFR1OP2 is possibly involved in some steps of the wound healing pathway.
=== Knight Bachelor === Alan Ayckbourn, , Playwright. For services to The Theatre. Jack Mervyn Frank Baer. For services to the Art Trade. Nicholas Brian Baker, , Member of Parliament for Dorset North. For political service. Alec Victor Bedser, . For services to Cricket. Thomas Leon Blundell, . For services to the Biotechnology and Biological Sciences Research Council and to Scientific Research. Alan Peter Budd, Chief Economic Adviser to Her Majesty's Treasury and Head, Government Economic Service. Peter John Davis, Chairman, National Advisory Council for Education and Training Targets. For services to Training and to Industry. Simon James Day. For political and public service. Geoffrey James Dear, , Her Majesty's Inspector of Constabulary. For services to the Police. Richard Charles Hastings Eyre, , Artistic Director, Royal National Theatre. For services to Drama. David Harrison, , Master, Selwyn College, University of Cambridge. For services to Education and to Nuclear Safety. John Smith Harvie, . For political and public service. Robert Baynes Horton, Chairman, Railtrack plc. For services to the Railway Industry. Gordon Minto Hourston, Chairman, Armed Forces' Pay Review Body. For services to the Armed Forces and to Industry. Michael Nicholas Howard Jenkins, , Chairman, Futures and Options Association and the London Clearing House. For services to the Finance Industry. John Martin Kirby Laing, , Chairman, John Laing plc. For services to the Construction Industry. James Paul McCartney, , Musician. For services to Music. Professor Samuel Roy Meadow.
In 2017, he was given the additional charge of Skill Development. As Labour Minister, Lad publicly supported women's participation in night-shift employment and opposed recommendations that women should be restricted from night work because of domestic responsibilities.
, for example in case of the mammalian mitochondrion: H+ / ATP = ΔGp / (Δp / 10.4 kJ·mol−1/mV) = 40.2 kJ·mol−1 / (173.5 mV / 10.4 kJ·mol−1/mV) = 40.2 / 16.7 = 2.4. The actual ratio of the proton-binding c-subunit to the ATP-synthesizing beta-subunit copy numbers is 8/3 = 2.67, showing that under these conditions, the mitochondrion functions at 90% (2.4/2.67) efficiency. In fact, the thermodynamic efficiency is mostly lower in eukaryotic cells because ATP must be exported from the matrix to the cytoplasm, and ADP and phosphate must be imported from the cytoplasm. This "costs" one "extra" proton import per ATP, hence the actual efficiency is only 65% (= 2.4/3.67).
Sources: en.wikipedia.org
Linear for two-coordination Trigonal planar for three-coordination Tetrahedral or square planar for four-coordination Trigonal bipyramidal for five-coordination Octahedral for six-coordination Pentagonal bipyramidal for seven-coordination Square antiprismatic for eight-coordination Tricapped trigonal prismatic for nine-coordination The idealized descriptions of 5-, 7-, 8-, and 9- coordination are often indistinct geometrically from alternative structures with slightly differing L-M-L (ligand-metal-ligand) angles, e.g. the difference between square pyramidal and trigonal bipyramidal structures.
=== Mixed === In mixed inhibition the inhibitor may bind to the enzyme whether or not the substrate has already bound. Hence mixed inhibition is a combination of competitive and noncompetitive inhibition. Furthermore, the affinity of the inhibitor for the free enzyme and the enzyme-substrate complex may differ. By increasing concentrations of substrate [S], this type of inhibition can be reduced (due to the competitive contribution), but not entirely overcome (due to the noncompetitive component). Although it is possible for mixed-type inhibitors to bind in the active site, this type of inhibition generally results from an allosteric effect where the inhibitor binds to a different site on an enzyme. Inhibitor binding to this allosteric site changes the conformation (that is, the tertiary structure or three-dimensional shape) of the enzyme so that the affinity of the substrate for the active site is reduced. These four types of inhibition can also be distinguished by the effect of increasing the substrate concentration [S] on the degree of inhibition caused by a given amount of inhibitor. For competitive inhibition the degree of inhibition is reduced by increasing [S], for noncompetitive inhibition the degree of inhibition is unchanged, and for uncompetitive (also called anticompetitive) inhibition the degree of inhibition increases with [S].
== Overview == Smoking most commonly leads to diseases affecting the heart and lungs and will commonly affect areas such as hands or feet. First signs of smoking-related health issues often show up as numbness in the extremities, with smoking being a major risk factor for heart attacks, chronic obstructive pulmonary disease (COPD), emphysema, and cancer, particularly lung cancer, cancers of the larynx and mouth, and pancreatic cancer. The immune system is also weakened by smoking, which makes the body more susceptible to infections and takes longer to recover from injuries. Overall life expectancy is also reduced in long term smokers, with estimates ranging from 10 to 17.9 years fewer than non-smokers. About half of men who smoke long-term will die of illness due to smoking. The association of smoking with lung cancer and COPD is among the strongest, both in the public perception and etiologically. Among male smokers, the lifetime risk of developing lung cancer is 17%; among female smokers, the risk is 12%. This risk is significantly lower in non-smokers: 1.3% in men and 1.4% in women. For COPD, the 25 year incidence of moderate and severe COPD is at least 21% for continuous smokers and 4% for non-smokers, with no difference being reported between men and women. A person's increased risk of contracting disease is related to the length of time that a person continues to smoke as well as the amount smoked. However, even smoking one cigarette a day raises the risk of coronary heart disease by about 50% or more, and for stroke by about 30%.
=== 21 April === Jens Stoltenberg, secretary general of NATO, said that "All NATO allies have agreed that Ukraine will become a member," once the war with Russia was over. German Defence Minister Boris Pistorius had previously said that it was not yet time to decide Ukraine's membership. A Moscow court ordered an arrest warrant, "in absentia", for Maj. Gen. Kyrylo Budanov, the head of the Main Directorate of Intelligence (Ukraine) over the Crimean Bridge explosion.
Sources: en.wikipedia.org
Reversed-phase liquid chromatography with ultraviolet detection gives a purity estimate, while mass spectrometry confirms molecular mass and flags modifications. Amino acid analysis can add compositional confirmation. Results are most meaningful when a validated reference standard is run alongside the sample.
Cold, dry, and dark conditions are standard, typically at or below minus twenty degrees Celsius for long-term holding. Vials are usually warmed to room temperature before opening to prevent condensation. Repeated warming and cooling of the same vial is generally avoided.
This depends on pH, buffer, and concentration, with acidic conditions often reported as more favorable. Hydrolysis accelerates at room temperature, so solutions are commonly prepared fresh or stored frozen in single-use aliquots. No single shelf life applies across formulations.
It does not occur in the form that is supplied commercially. Its sequence matches a fragment of a larger gastric protein, and the research material is produced synthetically in a laboratory. The fragment described in the early literature is generally the same synthetic pentadecapeptide.